Full Text
The Full Text of this article is available as a PDF (187.4 KB).
editorial . 1997 Jul 26;315(7102):200–201. doi: 10.1136/bmj.315.7102.200
Regulating the pharmaceutical industry.
PMCID: PMC2127150 PMID: 9253257
See letter "Pharmaceutical industry is invited to respond to amnesty for unreported trials." on page 683b.
See letter "Regulating the pharmaceutical industry. Australian scheme has disadvantages." in volume 316 on page 227c.
See letter "Regulating the pharmaceutical industry. General public does not support value system inherent in cost effectiveness analyses." in volume 316 on page 226a.
See letter "Regulating the pharmaceutical industry. Authors seem to have misunderstood pharmaceutical price regulation scheme." in volume 316 on page 226b.
See letter "Regulating the pharmaceutical industry. Regulation may no longer be necessary." in volume 316 on page 227b.
See letter "Regulating the pharmaceutical industry. Having rationing rules for new pharmaceuticals but not other treatments is senseless." in volume 316 on page 227a.
See letter "Regulating the pharmaceutical industry. Further controls would discourage companies from investing in research." in volume 316 on page 227d.